figshare
Browse
pone.0241766.g006.tif (704.82 kB)

Autocrine RTK driven migration and proliferation in BCa cell lines.

Download (704.82 kB)
figure
posted on 2021-07-22, 17:50 authored by Young H. Lee, Molly M. Lee, Dinuka M. De Silva, Arpita Roy, Cara E. Wright, Tiffany K. Wong, Rene Costello, Oluwole Olaku, Robert L. Grubb III, Piyush K. Agarwal, Andrea B. Apolo, Donald P. Bottaro

(A) Migration (16 h, 37°C) of serum deprived J82 cells previously transfected with siRNA directed against AXL (siAXL) or control siRNA (siControl), treated with Gas6 (5.7 nM) in the presence or absence of cabozantinib (cabo; 300 nM), relative to untreated cells. Values are the mean +/- SD from triplicate samples; asterisks indicate significant difference from control (p < 0.05; ns, not significant). All results are representative of at least 3 experiments. Inset: ethidium bromide visualization of PCR products specific for AXL mRNA (upper panel) or 18S rRNA (lower panel) resolved by agarose gel electrophoresis. (B) Migration (16 h, 37°C) of serum deprived FL3 cells previously transfected with siRNA directed against MST1R (siMST1R), CSF1R (siCSF1R) or control siRNA (siControl), treated with MST1 (5 nM) or CSF1 (10 nM) in the presence or absence of cabozantinib (cabo; 300 nM), relative to untreated cells. Values are the mean +/- SD from triplicate samples; asterisks indicate significant difference from untreated control (p < 0.05). All results are representative of at least 3 experiments. Inset: ethidium bromide visualization of PCR products specific for MST1R, (upper panel), CSF1R (middle panel), or 18S RNA (lower panel) resolved by agarose gel electrophoresis. (C) Proliferation (cell no. x 10−5, 6 d, 37°C) of 5637 (left) or J82 (right) cells in 1% FBS left untreated (control; circles) or treated with Gas6 alone (5.7 nM; squares), cabozantinib alone (300 nM, triangles) or Gas6 and cabozantinib (inverted triangles). Media with additives was replaced on days 1, 2, and 4; cells were counted on days 0, 3 and 6. Values are the mean +/- SD from triplicate samples; asterisks indicate significant difference from control (p < 0.05). (D) Proliferation (cell no. x 10−5, 6 d, 37°C) of FL3 cells in 1% FBS left untreated (control; circles) or treated with MST1 alone (5 nM; squares), cabozantinib alone (300 nM, triangles) or MST1 and cabozantinib (inverted triangles). Media replacement and cell counting as per panel C. Values are the mean +/- SD from triplicate samples; asterisks indicate significant difference from control (p < 0.05).

History